The Leukemia Atlas: Researchers unveil proteins that signal disease

Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after the initial diagnosis. To improve that survival rate, researchers have created an online atlas to identify and classify protein signatures present at AML diagnosis.

Leave a Reply

Your email address will not be published. Required fields are marked *